Thrombosis with thrombocytopenia syndrome (TTS) is a rare but life-threatening condition characterized by the combination of blood clots (thrombosis) and a low platelet count (thrombocytopenia).…
Heparin-induced thrombocytopenia (HIT) is a severe prothrombotic immune complication of heparin exposure, particularly concerning in the setting of percutaneous coronary intervention (PCI). Despite its thrombocytopenic…
Heparin-induced thrombocytopenia (HIT) is a life-threatening, immune-mediated complication of heparin therapy, characterized by a significant drop in platelet count and an increased risk of thrombosis.…
The Fontan procedure is a palliative surgical intervention performed in patients with single-ventricle congenital heart defects. This operation reroutes systemic venous return directly to the…
Heparin-induced thrombocytopenia (HIT) is a prothrombotic, immune-mediated adverse reaction to heparin exposure. Paradoxically, HIT causes thrombosis rather than bleeding, despite the hallmark of thrombocytopenia. It…
Thromboembolism due to prosthetic heart valves represents a significant clinical concern, particularly in patients with mechanical valve replacements. These complications arise when thrombi form on…
Thromboembolic disorders are conditions characterized by the abnormal formation and migration of blood clots within the circulatory system. These clots, or thrombi, may form in…
Thrombocytosis is defined as a sustained elevation in platelet count exceeding 450,000/μL. When occurring in the context of myeloproliferative neoplasms (MPNs), this hematologic abnormality is…
Thrombocytopenia is a common hematologic manifestation in patients with chronic hepatitis C virus (HCV) infection. It is characterized by a platelet count below 150,000/µL and…
Thrombocytopenia, defined as a platelet count below 150,000/µL, is a frequent hematological abnormality in patients with chronic hepatitis. It is most commonly observed in those…